Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

2021/43/B/NZ7/02855

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Collegium Medicum

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Paweł Maria Zajdel

Number of co-investigators in the project: 15

Call

OPUS 22 – announced on 2021-09-15

Amount awarded
3 601 928 PLN
Project start date
2022-07-18
Project end date
2027-07-17
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (4)

  1. Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats

    Authors:
    Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, Geoffrey Canet, Grzegorz Satała, Agnieszka Olejarz-Maciej, Joanna Gołębiowska, Rafał Kurczab, Wojciech Pietruś, Monika Kubacka, Christophe Moreau, Maria Walczak, Klaudia Blicharz-Futera, Ophélie Bento, Xavier Bantreil, Gilles Subra, Andrzej J. Bojarski, Frédéric Lamaty, Carine Becamel, Charleine Zussy, Séverine Chaumont-Dubel, Piotr Popik, Hugues Nury, Philippe Marin, Laurent Givalois, Paweł Zajdel
    Academic press:
    Journal of Medicinal Chemistry (year: 2023, volume: 21, pages: 14928–14947), Publisher: American Chemical Society
    Status:
    Published
    DOI:
    10.1021/acs.jmedchem.3c01482 – link to the publication
  2. Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms

    Authors:
    Piotr Popik, Ewelina Cyrano, Diana Piotrowska, Malgorzata Holuj, Joanna Golebiowska, Natalia Malikowska-Racia, Agnieszka Potasiewicz, Agnieszka Nikiforuk
    Academic press:
    Frontiers in Pharmacology (year: 2024, volume: 14, pages: 1329424), Publisher: Frontiers
    Status:
    Published
    DOI:
    10.3389/fphar.2023.1329424 – link to the publication
  3. Deep learning algorithms reveal increased social activity in rats at the onset of the dark phase of the light/dark cycle

    Authors:
    Piotr Popik, Ewelina Cyrano, Joanna Golebiowska, Natalia Malikowska-Racia, Agnieszka Potasiewicz, and Agnieszka Nikiforuk
    Academic press:
    PLOS One (year: 2024, volume: 19, pages: e0307794), Publisher: PLoS ONE
    Status:
    Published
    DOI:
    10.1371/journal.pone.0307794 – link to the publication
  4. Current development in sulfonamide derivatives to enable CNS-drug discovery

    Authors:
    Klaudia Blicharz-Futera, Michał Kamiński, Katarzyna Grychowska, Vittorio Canale, Paweł Zajdel
    Academic press:
    Bioorganic Chemistry (year: 2025, volume: 156, pages: 108076), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bioorg.2024.108076 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski